Category : Science and TechPublished on: October 25 2024
Share on facebook
Indian multinational pharmaceutical company Zydus Lifesciences Limited announced that its typhoid VI conjugate vaccine, ZyVac TCV, has received in-principle approval from the World Health Organization (WHO.